nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—FKBP1A—Cyclosporine—systemic lupus erythematosus	0.222	0.323	CbGbCtD
Temsirolimus—CYP3A7—Dapsone—systemic lupus erythematosus	0.0327	0.0477	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Dapsone—systemic lupus erythematosus	0.0327	0.0477	CbGbCtD
Temsirolimus—CYP3A5—Dapsone—systemic lupus erythematosus	0.0245	0.0358	CbGbCtD
Temsirolimus—CYP3A7—Hydrocortisone—systemic lupus erythematosus	0.0227	0.0332	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Hydrocortisone—systemic lupus erythematosus	0.0227	0.0332	CbGbCtD
Temsirolimus—CYP3A7—Cyclosporine—systemic lupus erythematosus	0.0215	0.0313	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Cyclosporine—systemic lupus erythematosus	0.0215	0.0313	CbGbCtD
Temsirolimus—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.0213	0.031	CbGbCtD
Temsirolimus—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0183	0.0266	CbGbCtD
Temsirolimus—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.0171	0.0249	CbGbCtD
Temsirolimus—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.0161	0.0235	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Dexamethasone—systemic lupus erythematosus	0.0141	0.0206	CbGbCtD
Temsirolimus—CYP3A7—Dexamethasone—systemic lupus erythematosus	0.0141	0.0206	CbGbCtD
Temsirolimus—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0138	0.0202	CbGbCtD
Temsirolimus—ABCB1—Betamethasone—systemic lupus erythematosus	0.0119	0.0173	CbGbCtD
Temsirolimus—ABCB1—Prednisolone—systemic lupus erythematosus	0.0117	0.0171	CbGbCtD
Temsirolimus—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0111	0.0162	CbGbCtD
Temsirolimus—ABCB1—Prednisone—systemic lupus erythematosus	0.0111	0.0161	CbGbCtD
Temsirolimus—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0109	0.016	CbGbCtD
Temsirolimus—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.0106	0.0155	CbGbCtD
Temsirolimus—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0105	0.0153	CbGbCtD
Temsirolimus—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.00988	0.0144	CbGbCtD
Temsirolimus—CYP3A4—Dapsone—systemic lupus erythematosus	0.00956	0.014	CbGbCtD
Temsirolimus—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00829	0.0121	CbGbCtD
Temsirolimus—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00829	0.0121	CbGbCtD
Temsirolimus—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00711	0.0104	CbGbCtD
Temsirolimus—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00702	0.0102	CbGbCtD
Temsirolimus—ABCB1—Dexamethasone—systemic lupus erythematosus	0.0069	0.0101	CbGbCtD
Temsirolimus—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00665	0.00971	CbGbCtD
Temsirolimus—CYP3A4—Prednisone—systemic lupus erythematosus	0.00663	0.00967	CbGbCtD
Temsirolimus—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.0065	0.00949	CbGbCtD
Temsirolimus—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00628	0.00917	CbGbCtD
Temsirolimus—ABCB1—Methotrexate—systemic lupus erythematosus	0.00555	0.0081	CbGbCtD
Temsirolimus—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00414	0.00604	CbGbCtD
Temsirolimus—MTOR—blood plasma—systemic lupus erythematosus	0.00321	0.0713	CbGeAlD
Temsirolimus—FKBP1A—blood plasma—systemic lupus erythematosus	0.00288	0.0641	CbGeAlD
Temsirolimus—CYP3A4—urine—systemic lupus erythematosus	0.00181	0.0401	CbGeAlD
Temsirolimus—CYP2D6—urine—systemic lupus erythematosus	0.00178	0.0395	CbGeAlD
Temsirolimus—MTOR—connective tissue—systemic lupus erythematosus	0.00171	0.0379	CbGeAlD
Temsirolimus—CYP3A7-CYP3A51P—nephron tubule—systemic lupus erythematosus	0.00156	0.0348	CbGeAlD
Temsirolimus—MTOR—skin of body—systemic lupus erythematosus	0.00154	0.0343	CbGeAlD
Temsirolimus—FKBP1A—connective tissue—systemic lupus erythematosus	0.00154	0.0341	CbGeAlD
Temsirolimus—MTOR—kidney—systemic lupus erythematosus	0.00145	0.0323	CbGeAlD
Temsirolimus—FKBP1A—skin of body—systemic lupus erythematosus	0.00139	0.0308	CbGeAlD
Temsirolimus—CYP3A7-CYP3A51P—cortex of kidney—systemic lupus erythematosus	0.00134	0.0298	CbGeAlD
Temsirolimus—FKBP1A—kidney—systemic lupus erythematosus	0.00131	0.029	CbGeAlD
Temsirolimus—FKBP1A—cortex of kidney—systemic lupus erythematosus	0.00127	0.0283	CbGeAlD
Temsirolimus—CYP3A5—blood plasma—systemic lupus erythematosus	0.00126	0.0279	CbGeAlD
Temsirolimus—MTOR—lymphoid tissue—systemic lupus erythematosus	0.00125	0.0277	CbGeAlD
Temsirolimus—MTOR—tendon—systemic lupus erythematosus	0.00117	0.0261	CbGeAlD
Temsirolimus—MTOR—bone marrow—systemic lupus erythematosus	0.00114	0.0253	CbGeAlD
Temsirolimus—FKBP1A—lymphoid tissue—systemic lupus erythematosus	0.00112	0.0249	CbGeAlD
Temsirolimus—FKBP1A—tendon—systemic lupus erythematosus	0.00106	0.0235	CbGeAlD
Temsirolimus—MTOR—lung—systemic lupus erythematosus	0.00103	0.0229	CbGeAlD
Temsirolimus—FKBP1A—bone marrow—systemic lupus erythematosus	0.00102	0.0227	CbGeAlD
Temsirolimus—MTOR—nervous system—systemic lupus erythematosus	0.000954	0.0212	CbGeAlD
Temsirolimus—CYP3A4—blood plasma—systemic lupus erythematosus	0.000942	0.0209	CbGeAlD
Temsirolimus—CYP2D6—blood plasma—systemic lupus erythematosus	0.000927	0.0206	CbGeAlD
Temsirolimus—FKBP1A—lung—systemic lupus erythematosus	0.000926	0.0206	CbGeAlD
Temsirolimus—MTOR—central nervous system—systemic lupus erythematosus	0.000918	0.0204	CbGeAlD
Temsirolimus—FKBP1A—nervous system—systemic lupus erythematosus	0.000858	0.0191	CbGeAlD
Temsirolimus—FKBP1A—central nervous system—systemic lupus erythematosus	0.000826	0.0183	CbGeAlD
Temsirolimus—ABCB1—blood plasma—systemic lupus erythematosus	0.000667	0.0148	CbGeAlD
Temsirolimus—CYP3A5—nephron tubule—systemic lupus erythematosus	0.000648	0.0144	CbGeAlD
Temsirolimus—CYP3A5—kidney—systemic lupus erythematosus	0.000569	0.0126	CbGeAlD
Temsirolimus—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.000554	0.0123	CbGeAlD
Temsirolimus—CYP3A4—kidney—systemic lupus erythematosus	0.000427	0.00949	CbGeAlD
Temsirolimus—CYP2D6—kidney—systemic lupus erythematosus	0.00042	0.00934	CbGeAlD
Temsirolimus—CYP3A5—lung—systemic lupus erythematosus	0.000403	0.00896	CbGeAlD
Temsirolimus—ABCB1—nephron tubule—systemic lupus erythematosus	0.000344	0.00765	CbGeAlD
Temsirolimus—ABCB1—kidney—systemic lupus erythematosus	0.000302	0.00672	CbGeAlD
Temsirolimus—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000294	0.00654	CbGeAlD
Temsirolimus—CYP3A4—nervous system—systemic lupus erythematosus	0.00028	0.00623	CbGeAlD
Temsirolimus—CYP2D6—nervous system—systemic lupus erythematosus	0.000276	0.00613	CbGeAlD
Temsirolimus—CYP3A4—central nervous system—systemic lupus erythematosus	0.00027	0.006	CbGeAlD
Temsirolimus—CYP2D6—central nervous system—systemic lupus erythematosus	0.000266	0.0059	CbGeAlD
Temsirolimus—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.00026	0.00577	CbGeAlD
Temsirolimus—ABCB1—bone marrow—systemic lupus erythematosus	0.000236	0.00525	CbGeAlD
Temsirolimus—ABCB1—lung—systemic lupus erythematosus	0.000214	0.00476	CbGeAlD
Temsirolimus—ABCB1—nervous system—systemic lupus erythematosus	0.000198	0.00441	CbGeAlD
Temsirolimus—ABCB1—central nervous system—systemic lupus erythematosus	0.000191	0.00424	CbGeAlD
Temsirolimus—Angioedema—Dexamethasone—systemic lupus erythematosus	0.000105	0.000555	CcSEcCtD
Temsirolimus—Angioedema—Betamethasone—systemic lupus erythematosus	0.000105	0.000555	CcSEcCtD
Temsirolimus—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	0.000104	0.000553	CcSEcCtD
Temsirolimus—Anorexia—Hydrocortisone—systemic lupus erythematosus	0.000104	0.000553	CcSEcCtD
Temsirolimus—Stomatitis—Methotrexate—systemic lupus erythematosus	0.000104	0.000551	CcSEcCtD
Temsirolimus—Angiopathy—Prednisone—systemic lupus erythematosus	0.000104	0.000551	CcSEcCtD
Temsirolimus—Conjunctivitis—Methotrexate—systemic lupus erythematosus	0.000104	0.00055	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000104	0.00055	CcSEcCtD
Temsirolimus—Immune system disorder—Prednisone—systemic lupus erythematosus	0.000103	0.000549	CcSEcCtD
Temsirolimus—Anaphylactic shock—Triamcinolone—systemic lupus erythematosus	0.000103	0.000546	CcSEcCtD
Temsirolimus—Oedema—Triamcinolone—systemic lupus erythematosus	0.000103	0.000546	CcSEcCtD
Temsirolimus—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	0.000103	0.000545	CcSEcCtD
Temsirolimus—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000103	0.000544	CcSEcCtD
Temsirolimus—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000103	0.000544	CcSEcCtD
Temsirolimus—Infection—Triamcinolone—systemic lupus erythematosus	0.000102	0.000543	CcSEcCtD
Temsirolimus—Infection—Methylprednisolone—systemic lupus erythematosus	0.000102	0.000541	CcSEcCtD
Temsirolimus—Haematuria—Methotrexate—systemic lupus erythematosus	0.000102	0.000539	CcSEcCtD
Temsirolimus—Vomiting—Leflunomide—systemic lupus erythematosus	0.000101	0.000538	CcSEcCtD
Temsirolimus—Insomnia—Prednisolone—systemic lupus erythematosus	0.000101	0.000537	CcSEcCtD
Temsirolimus—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.000101	0.000534	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.000101	0.000534	CcSEcCtD
Temsirolimus—Epistaxis—Methotrexate—systemic lupus erythematosus	0.000101	0.000533	CcSEcCtD
Temsirolimus—Rash—Leflunomide—systemic lupus erythematosus	0.0001	0.000533	CcSEcCtD
Temsirolimus—Dermatitis—Leflunomide—systemic lupus erythematosus	0.0001	0.000533	CcSEcCtD
Temsirolimus—Mental disorder—Prednisone—systemic lupus erythematosus	0.0001	0.000532	CcSEcCtD
Temsirolimus—Nausea—Azathioprine—systemic lupus erythematosus	0.0001	0.000532	CcSEcCtD
Temsirolimus—Headache—Leflunomide—systemic lupus erythematosus	9.98e-05	0.00053	CcSEcCtD
Temsirolimus—Skin disorder—Methylprednisolone—systemic lupus erythematosus	9.97e-05	0.000529	CcSEcCtD
Temsirolimus—Malnutrition—Prednisone—systemic lupus erythematosus	9.96e-05	0.000529	CcSEcCtD
Temsirolimus—Erythema—Prednisone—systemic lupus erythematosus	9.96e-05	0.000529	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	9.96e-05	0.000528	CcSEcCtD
Temsirolimus—Convulsion—Betamethasone—systemic lupus erythematosus	9.91e-05	0.000526	CcSEcCtD
Temsirolimus—Convulsion—Dexamethasone—systemic lupus erythematosus	9.91e-05	0.000526	CcSEcCtD
Temsirolimus—Insomnia—Hydrocortisone—systemic lupus erythematosus	9.89e-05	0.000525	CcSEcCtD
Temsirolimus—Hypertension—Betamethasone—systemic lupus erythematosus	9.88e-05	0.000524	CcSEcCtD
Temsirolimus—Hypertension—Dexamethasone—systemic lupus erythematosus	9.88e-05	0.000524	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	9.81e-05	0.000521	CcSEcCtD
Temsirolimus—Myalgia—Dexamethasone—systemic lupus erythematosus	9.74e-05	0.000517	CcSEcCtD
Temsirolimus—Myalgia—Betamethasone—systemic lupus erythematosus	9.74e-05	0.000517	CcSEcCtD
Temsirolimus—Abdominal pain—Cyclosporine—systemic lupus erythematosus	9.72e-05	0.000516	CcSEcCtD
Temsirolimus—Body temperature increased—Cyclosporine—systemic lupus erythematosus	9.72e-05	0.000516	CcSEcCtD
Temsirolimus—Anxiety—Dexamethasone—systemic lupus erythematosus	9.71e-05	0.000515	CcSEcCtD
Temsirolimus—Anxiety—Betamethasone—systemic lupus erythematosus	9.71e-05	0.000515	CcSEcCtD
Temsirolimus—Pain—Prednisolone—systemic lupus erythematosus	9.57e-05	0.000508	CcSEcCtD
Temsirolimus—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	9.5e-05	0.000504	CcSEcCtD
Temsirolimus—Pharyngitis—Methotrexate—systemic lupus erythematosus	9.49e-05	0.000504	CcSEcCtD
Temsirolimus—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	9.48e-05	0.000503	CcSEcCtD
Temsirolimus—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	9.48e-05	0.000503	CcSEcCtD
Temsirolimus—Nausea—Leflunomide—systemic lupus erythematosus	9.47e-05	0.000502	CcSEcCtD
Temsirolimus—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	9.45e-05	0.000501	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	9.44e-05	0.000501	CcSEcCtD
Temsirolimus—Fatigue—Hydrocortisone—systemic lupus erythematosus	9.42e-05	0.0005	CcSEcCtD
Temsirolimus—Urethral disorder—Methotrexate—systemic lupus erythematosus	9.38e-05	0.000498	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	9.38e-05	0.000498	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	9.36e-05	0.000496	CcSEcCtD
Temsirolimus—Pain—Hydrocortisone—systemic lupus erythematosus	9.35e-05	0.000496	CcSEcCtD
Temsirolimus—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	9.34e-05	0.000496	CcSEcCtD
Temsirolimus—Oedema—Betamethasone—systemic lupus erythematosus	9.34e-05	0.000496	CcSEcCtD
Temsirolimus—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	9.34e-05	0.000496	CcSEcCtD
Temsirolimus—Oedema—Dexamethasone—systemic lupus erythematosus	9.34e-05	0.000496	CcSEcCtD
Temsirolimus—Insomnia—Triamcinolone—systemic lupus erythematosus	9.31e-05	0.000494	CcSEcCtD
Temsirolimus—Insomnia—Methylprednisolone—systemic lupus erythematosus	9.29e-05	0.000493	CcSEcCtD
Temsirolimus—Infection—Betamethasone—systemic lupus erythematosus	9.28e-05	0.000492	CcSEcCtD
Temsirolimus—Infection—Dexamethasone—systemic lupus erythematosus	9.28e-05	0.000492	CcSEcCtD
Temsirolimus—Anaemia—Prednisone—systemic lupus erythematosus	9.21e-05	0.000489	CcSEcCtD
Temsirolimus—Dyspnoea—Triamcinolone—systemic lupus erythematosus	9.18e-05	0.000487	CcSEcCtD
Temsirolimus—Nervous system disorder—Betamethasone—systemic lupus erythematosus	9.16e-05	0.000486	CcSEcCtD
Temsirolimus—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	9.16e-05	0.000486	CcSEcCtD
Temsirolimus—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	9.14e-05	0.000485	CcSEcCtD
Temsirolimus—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	9.14e-05	0.000485	CcSEcCtD
Temsirolimus—Angioedema—Prednisone—systemic lupus erythematosus	9.1e-05	0.000483	CcSEcCtD
Temsirolimus—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	9.06e-05	0.000481	CcSEcCtD
Temsirolimus—Erythema multiforme—Methotrexate—systemic lupus erythematosus	9.04e-05	0.00048	CcSEcCtD
Temsirolimus—Eye disorder—Methotrexate—systemic lupus erythematosus	8.94e-05	0.000474	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	8.94e-05	0.000474	CcSEcCtD
Temsirolimus—Anorexia—Betamethasone—systemic lupus erythematosus	8.9e-05	0.000472	CcSEcCtD
Temsirolimus—Anorexia—Dexamethasone—systemic lupus erythematosus	8.9e-05	0.000472	CcSEcCtD
Temsirolimus—Cardiac disorder—Methotrexate—systemic lupus erythematosus	8.88e-05	0.000471	CcSEcCtD
Temsirolimus—Fatigue—Triamcinolone—systemic lupus erythematosus	8.87e-05	0.000471	CcSEcCtD
Temsirolimus—Fatigue—Methylprednisolone—systemic lupus erythematosus	8.85e-05	0.00047	CcSEcCtD
Temsirolimus—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	8.84e-05	0.000469	CcSEcCtD
Temsirolimus—Asthenia—Cyclosporine—systemic lupus erythematosus	8.82e-05	0.000468	CcSEcCtD
Temsirolimus—Pain—Triamcinolone—systemic lupus erythematosus	8.8e-05	0.000467	CcSEcCtD
Temsirolimus—Pruritus—Cyclosporine—systemic lupus erythematosus	8.7e-05	0.000462	CcSEcCtD
Temsirolimus—Angiopathy—Methotrexate—systemic lupus erythematosus	8.68e-05	0.000461	CcSEcCtD
Temsirolimus—Immune system disorder—Methotrexate—systemic lupus erythematosus	8.64e-05	0.000459	CcSEcCtD
Temsirolimus—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	8.64e-05	0.000458	CcSEcCtD
Temsirolimus—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	8.64e-05	0.000458	CcSEcCtD
Temsirolimus—Convulsion—Prednisone—systemic lupus erythematosus	8.63e-05	0.000458	CcSEcCtD
Temsirolimus—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	8.62e-05	0.000457	CcSEcCtD
Temsirolimus—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	8.61e-05	0.000457	CcSEcCtD
Temsirolimus—Hypertension—Prednisone—systemic lupus erythematosus	8.6e-05	0.000457	CcSEcCtD
Temsirolimus—Chills—Methotrexate—systemic lupus erythematosus	8.58e-05	0.000455	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	8.51e-05	0.000451	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	8.51e-05	0.000451	CcSEcCtD
Temsirolimus—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	8.49e-05	0.00045	CcSEcCtD
Temsirolimus—Arthralgia—Prednisone—systemic lupus erythematosus	8.48e-05	0.00045	CcSEcCtD
Temsirolimus—Myalgia—Prednisone—systemic lupus erythematosus	8.48e-05	0.00045	CcSEcCtD
Temsirolimus—Anxiety—Prednisone—systemic lupus erythematosus	8.45e-05	0.000449	CcSEcCtD
Temsirolimus—Insomnia—Betamethasone—systemic lupus erythematosus	8.45e-05	0.000448	CcSEcCtD
Temsirolimus—Insomnia—Dexamethasone—systemic lupus erythematosus	8.45e-05	0.000448	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	8.42e-05	0.000447	CcSEcCtD
Temsirolimus—Diarrhoea—Cyclosporine—systemic lupus erythematosus	8.41e-05	0.000447	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	8.4e-05	0.000446	CcSEcCtD
Temsirolimus—Mental disorder—Methotrexate—systemic lupus erythematosus	8.38e-05	0.000445	CcSEcCtD
Temsirolimus—Erythema—Methotrexate—systemic lupus erythematosus	8.33e-05	0.000442	CcSEcCtD
Temsirolimus—Malnutrition—Methotrexate—systemic lupus erythematosus	8.33e-05	0.000442	CcSEcCtD
Temsirolimus—Hypersensitivity—Prednisolone—systemic lupus erythematosus	8.25e-05	0.000438	CcSEcCtD
Temsirolimus—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	8.21e-05	0.000436	CcSEcCtD
Temsirolimus—Dysgeusia—Methotrexate—systemic lupus erythematosus	8.15e-05	0.000433	CcSEcCtD
Temsirolimus—Body temperature increased—Triamcinolone—systemic lupus erythematosus	8.14e-05	0.000432	CcSEcCtD
Temsirolimus—Dizziness—Cyclosporine—systemic lupus erythematosus	8.13e-05	0.000432	CcSEcCtD
Temsirolimus—Anaphylactic shock—Prednisone—systemic lupus erythematosus	8.13e-05	0.000432	CcSEcCtD
Temsirolimus—Oedema—Prednisone—systemic lupus erythematosus	8.13e-05	0.000432	CcSEcCtD
Temsirolimus—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	8.12e-05	0.000431	CcSEcCtD
Temsirolimus—Decreased appetite—Dexamethasone—systemic lupus erythematosus	8.12e-05	0.000431	CcSEcCtD
Temsirolimus—Decreased appetite—Betamethasone—systemic lupus erythematosus	8.12e-05	0.000431	CcSEcCtD
Temsirolimus—Infection—Prednisone—systemic lupus erythematosus	8.08e-05	0.000429	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	8.06e-05	0.000428	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	8.06e-05	0.000428	CcSEcCtD
Temsirolimus—Back pain—Methotrexate—systemic lupus erythematosus	8.06e-05	0.000427	CcSEcCtD
Temsirolimus—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	8.05e-05	0.000427	CcSEcCtD
Temsirolimus—Fatigue—Betamethasone—systemic lupus erythematosus	8.05e-05	0.000427	CcSEcCtD
Temsirolimus—Fatigue—Dexamethasone—systemic lupus erythematosus	8.05e-05	0.000427	CcSEcCtD
Temsirolimus—Pain—Dexamethasone—systemic lupus erythematosus	7.99e-05	0.000424	CcSEcCtD
Temsirolimus—Pain—Betamethasone—systemic lupus erythematosus	7.99e-05	0.000424	CcSEcCtD
Temsirolimus—Nervous system disorder—Prednisone—systemic lupus erythematosus	7.98e-05	0.000423	CcSEcCtD
Temsirolimus—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	7.93e-05	0.000421	CcSEcCtD
Temsirolimus—Skin disorder—Prednisone—systemic lupus erythematosus	7.9e-05	0.000419	CcSEcCtD
Temsirolimus—Asthenia—Hydrocortisone—systemic lupus erythematosus	7.84e-05	0.000416	CcSEcCtD
Temsirolimus—Vomiting—Cyclosporine—systemic lupus erythematosus	7.82e-05	0.000415	CcSEcCtD
Temsirolimus—Rash—Cyclosporine—systemic lupus erythematosus	7.75e-05	0.000411	CcSEcCtD
Temsirolimus—Anorexia—Prednisone—systemic lupus erythematosus	7.75e-05	0.000411	CcSEcCtD
Temsirolimus—Dermatitis—Cyclosporine—systemic lupus erythematosus	7.75e-05	0.000411	CcSEcCtD
Temsirolimus—Pruritus—Hydrocortisone—systemic lupus erythematosus	7.73e-05	0.00041	CcSEcCtD
Temsirolimus—Headache—Cyclosporine—systemic lupus erythematosus	7.7e-05	0.000409	CcSEcCtD
Temsirolimus—Anaemia—Methotrexate—systemic lupus erythematosus	7.7e-05	0.000408	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	7.64e-05	0.000405	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	7.64e-05	0.000405	CcSEcCtD
Temsirolimus—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	7.63e-05	0.000405	CcSEcCtD
Temsirolimus—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	7.58e-05	0.000402	CcSEcCtD
Temsirolimus—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	7.57e-05	0.000401	CcSEcCtD
Temsirolimus—Rash—Mycophenolate mofetil—systemic lupus erythematosus	7.56e-05	0.000401	CcSEcCtD
Temsirolimus—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	7.56e-05	0.000401	CcSEcCtD
Temsirolimus—Headache—Mycophenolate mofetil—systemic lupus erythematosus	7.52e-05	0.000399	CcSEcCtD
Temsirolimus—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	7.48e-05	0.000397	CcSEcCtD
Temsirolimus—Leukopenia—Methotrexate—systemic lupus erythematosus	7.45e-05	0.000396	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	7.41e-05	0.000393	CcSEcCtD
Temsirolimus—Dizziness—Prednisolone—systemic lupus erythematosus	7.4e-05	0.000393	CcSEcCtD
Temsirolimus—Asthenia—Triamcinolone—systemic lupus erythematosus	7.38e-05	0.000392	CcSEcCtD
Temsirolimus—Abdominal pain—Dexamethasone—systemic lupus erythematosus	7.38e-05	0.000392	CcSEcCtD
Temsirolimus—Body temperature increased—Betamethasone—systemic lupus erythematosus	7.38e-05	0.000392	CcSEcCtD
Temsirolimus—Body temperature increased—Dexamethasone—systemic lupus erythematosus	7.38e-05	0.000392	CcSEcCtD
Temsirolimus—Abdominal pain—Betamethasone—systemic lupus erythematosus	7.38e-05	0.000392	CcSEcCtD
Temsirolimus—Asthenia—Methylprednisolone—systemic lupus erythematosus	7.37e-05	0.000391	CcSEcCtD
Temsirolimus—Insomnia—Prednisone—systemic lupus erythematosus	7.36e-05	0.00039	CcSEcCtD
Temsirolimus—Nausea—Cyclosporine—systemic lupus erythematosus	7.3e-05	0.000388	CcSEcCtD
Temsirolimus—Pruritus—Triamcinolone—systemic lupus erythematosus	7.28e-05	0.000386	CcSEcCtD
Temsirolimus—Cough—Methotrexate—systemic lupus erythematosus	7.27e-05	0.000386	CcSEcCtD
Temsirolimus—Pruritus—Methylprednisolone—systemic lupus erythematosus	7.26e-05	0.000386	CcSEcCtD
Temsirolimus—Dizziness—Hydrocortisone—systemic lupus erythematosus	7.23e-05	0.000384	CcSEcCtD
Temsirolimus—Convulsion—Methotrexate—systemic lupus erythematosus	7.22e-05	0.000383	CcSEcCtD
Temsirolimus—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	7.13e-05	0.000378	CcSEcCtD
Temsirolimus—Arthralgia—Methotrexate—systemic lupus erythematosus	7.09e-05	0.000376	CcSEcCtD
Temsirolimus—Myalgia—Methotrexate—systemic lupus erythematosus	7.09e-05	0.000376	CcSEcCtD
Temsirolimus—Chest pain—Methotrexate—systemic lupus erythematosus	7.09e-05	0.000376	CcSEcCtD
Temsirolimus—Decreased appetite—Prednisone—systemic lupus erythematosus	7.07e-05	0.000375	CcSEcCtD
Temsirolimus—Rash—Prednisolone—systemic lupus erythematosus	7.06e-05	0.000374	CcSEcCtD
Temsirolimus—Dermatitis—Prednisolone—systemic lupus erythematosus	7.05e-05	0.000374	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	7.04e-05	0.000374	CcSEcCtD
Temsirolimus—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	7.03e-05	0.000373	CcSEcCtD
Temsirolimus—Fatigue—Prednisone—systemic lupus erythematosus	7.01e-05	0.000372	CcSEcCtD
Temsirolimus—Headache—Prednisolone—systemic lupus erythematosus	7.01e-05	0.000372	CcSEcCtD
Temsirolimus—Constipation—Prednisone—systemic lupus erythematosus	6.95e-05	0.000369	CcSEcCtD
Temsirolimus—Vomiting—Hydrocortisone—systemic lupus erythematosus	6.95e-05	0.000369	CcSEcCtD
Temsirolimus—Rash—Hydrocortisone—systemic lupus erythematosus	6.89e-05	0.000366	CcSEcCtD
Temsirolimus—Dermatitis—Hydrocortisone—systemic lupus erythematosus	6.89e-05	0.000365	CcSEcCtD
Temsirolimus—Headache—Hydrocortisone—systemic lupus erythematosus	6.85e-05	0.000363	CcSEcCtD
Temsirolimus—Dizziness—Triamcinolone—systemic lupus erythematosus	6.81e-05	0.000361	CcSEcCtD
Temsirolimus—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	6.8e-05	0.000361	CcSEcCtD
Temsirolimus—Dizziness—Methylprednisolone—systemic lupus erythematosus	6.79e-05	0.00036	CcSEcCtD
Temsirolimus—Infection—Methotrexate—systemic lupus erythematosus	6.75e-05	0.000358	CcSEcCtD
Temsirolimus—Asthenia—Dexamethasone—systemic lupus erythematosus	6.7e-05	0.000356	CcSEcCtD
Temsirolimus—Asthenia—Betamethasone—systemic lupus erythematosus	6.7e-05	0.000356	CcSEcCtD
Temsirolimus—Nervous system disorder—Methotrexate—systemic lupus erythematosus	6.66e-05	0.000354	CcSEcCtD
Temsirolimus—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	6.65e-05	0.000353	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	6.65e-05	0.000353	CcSEcCtD
Temsirolimus—Nausea—Prednisolone—systemic lupus erythematosus	6.65e-05	0.000353	CcSEcCtD
Temsirolimus—Pruritus—Dexamethasone—systemic lupus erythematosus	6.61e-05	0.000351	CcSEcCtD
Temsirolimus—Pruritus—Betamethasone—systemic lupus erythematosus	6.61e-05	0.000351	CcSEcCtD
Temsirolimus—Skin disorder—Methotrexate—systemic lupus erythematosus	6.6e-05	0.00035	CcSEcCtD
Temsirolimus—Vomiting—Triamcinolone—systemic lupus erythematosus	6.54e-05	0.000347	CcSEcCtD
Temsirolimus—Vomiting—Methylprednisolone—systemic lupus erythematosus	6.53e-05	0.000346	CcSEcCtD
Temsirolimus—Nausea—Hydrocortisone—systemic lupus erythematosus	6.49e-05	0.000345	CcSEcCtD
Temsirolimus—Rash—Triamcinolone—systemic lupus erythematosus	6.49e-05	0.000344	CcSEcCtD
Temsirolimus—Dermatitis—Triamcinolone—systemic lupus erythematosus	6.48e-05	0.000344	CcSEcCtD
Temsirolimus—Anorexia—Methotrexate—systemic lupus erythematosus	6.48e-05	0.000344	CcSEcCtD
Temsirolimus—Rash—Methylprednisolone—systemic lupus erythematosus	6.47e-05	0.000344	CcSEcCtD
Temsirolimus—Dermatitis—Methylprednisolone—systemic lupus erythematosus	6.47e-05	0.000343	CcSEcCtD
Temsirolimus—Headache—Triamcinolone—systemic lupus erythematosus	6.45e-05	0.000342	CcSEcCtD
Temsirolimus—Headache—Methylprednisolone—systemic lupus erythematosus	6.43e-05	0.000341	CcSEcCtD
Temsirolimus—Body temperature increased—Prednisone—systemic lupus erythematosus	6.43e-05	0.000341	CcSEcCtD
Temsirolimus—Abdominal pain—Prednisone—systemic lupus erythematosus	6.43e-05	0.000341	CcSEcCtD
Temsirolimus—Diarrhoea—Dexamethasone—systemic lupus erythematosus	6.39e-05	0.000339	CcSEcCtD
Temsirolimus—Diarrhoea—Betamethasone—systemic lupus erythematosus	6.39e-05	0.000339	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	6.19e-05	0.000329	CcSEcCtD
Temsirolimus—Dizziness—Betamethasone—systemic lupus erythematosus	6.18e-05	0.000328	CcSEcCtD
Temsirolimus—Dizziness—Dexamethasone—systemic lupus erythematosus	6.18e-05	0.000328	CcSEcCtD
Temsirolimus—Insomnia—Methotrexate—systemic lupus erythematosus	6.15e-05	0.000326	CcSEcCtD
Temsirolimus—Nausea—Triamcinolone—systemic lupus erythematosus	6.11e-05	0.000324	CcSEcCtD
Temsirolimus—Nausea—Methylprednisolone—systemic lupus erythematosus	6.1e-05	0.000324	CcSEcCtD
Temsirolimus—Dyspnoea—Methotrexate—systemic lupus erythematosus	6.06e-05	0.000322	CcSEcCtD
Temsirolimus—Somnolence—Methotrexate—systemic lupus erythematosus	6.04e-05	0.000321	CcSEcCtD
Temsirolimus—Hypersensitivity—Prednisone—systemic lupus erythematosus	5.99e-05	0.000318	CcSEcCtD
Temsirolimus—Vomiting—Dexamethasone—systemic lupus erythematosus	5.94e-05	0.000315	CcSEcCtD
Temsirolimus—Vomiting—Betamethasone—systemic lupus erythematosus	5.94e-05	0.000315	CcSEcCtD
Temsirolimus—Decreased appetite—Methotrexate—systemic lupus erythematosus	5.91e-05	0.000314	CcSEcCtD
Temsirolimus—Rash—Betamethasone—systemic lupus erythematosus	5.89e-05	0.000312	CcSEcCtD
Temsirolimus—Rash—Dexamethasone—systemic lupus erythematosus	5.89e-05	0.000312	CcSEcCtD
Temsirolimus—Dermatitis—Betamethasone—systemic lupus erythematosus	5.88e-05	0.000312	CcSEcCtD
Temsirolimus—Dermatitis—Dexamethasone—systemic lupus erythematosus	5.88e-05	0.000312	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	5.87e-05	0.000311	CcSEcCtD
Temsirolimus—Fatigue—Methotrexate—systemic lupus erythematosus	5.86e-05	0.000311	CcSEcCtD
Temsirolimus—Headache—Betamethasone—systemic lupus erythematosus	5.85e-05	0.00031	CcSEcCtD
Temsirolimus—Headache—Dexamethasone—systemic lupus erythematosus	5.85e-05	0.00031	CcSEcCtD
Temsirolimus—Asthenia—Prednisone—systemic lupus erythematosus	5.83e-05	0.00031	CcSEcCtD
Temsirolimus—Pain—Methotrexate—systemic lupus erythematosus	5.81e-05	0.000308	CcSEcCtD
Temsirolimus—Pruritus—Prednisone—systemic lupus erythematosus	5.75e-05	0.000305	CcSEcCtD
Temsirolimus—Diarrhoea—Prednisone—systemic lupus erythematosus	5.56e-05	0.000295	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	5.56e-05	0.000295	CcSEcCtD
Temsirolimus—Nausea—Betamethasone—systemic lupus erythematosus	5.55e-05	0.000294	CcSEcCtD
Temsirolimus—Nausea—Dexamethasone—systemic lupus erythematosus	5.55e-05	0.000294	CcSEcCtD
Temsirolimus—Dizziness—Prednisone—systemic lupus erythematosus	5.38e-05	0.000285	CcSEcCtD
Temsirolimus—Abdominal pain—Methotrexate—systemic lupus erythematosus	5.37e-05	0.000285	CcSEcCtD
Temsirolimus—Body temperature increased—Methotrexate—systemic lupus erythematosus	5.37e-05	0.000285	CcSEcCtD
Temsirolimus—Vomiting—Prednisone—systemic lupus erythematosus	5.17e-05	0.000274	CcSEcCtD
Temsirolimus—Rash—Prednisone—systemic lupus erythematosus	5.13e-05	0.000272	CcSEcCtD
Temsirolimus—Dermatitis—Prednisone—systemic lupus erythematosus	5.12e-05	0.000272	CcSEcCtD
Temsirolimus—Headache—Prednisone—systemic lupus erythematosus	5.09e-05	0.00027	CcSEcCtD
Temsirolimus—MTOR—B Cell Activation—CDKN1B—systemic lupus erythematosus	5.07e-05	0.000623	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—CDKN1A—systemic lupus erythematosus	5.05e-05	0.000621	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—CDKN1A—systemic lupus erythematosus	5.05e-05	0.000621	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—CDKN1A—systemic lupus erythematosus	5.05e-05	0.000621	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IFNA1—systemic lupus erythematosus	5.03e-05	0.000619	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—CDKN1A—systemic lupus erythematosus	5.01e-05	0.000616	CbGpPWpGaD
Temsirolimus—Hypersensitivity—Methotrexate—systemic lupus erythematosus	5.01e-05	0.000266	CcSEcCtD
Temsirolimus—MTOR—Adaptive Immune System—CD40—systemic lupus erythematosus	4.99e-05	0.000614	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—CDKN1A—systemic lupus erythematosus	4.96e-05	0.00061	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IFNG—systemic lupus erythematosus	4.95e-05	0.000608	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—CDKN1A—systemic lupus erythematosus	4.94e-05	0.000608	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	4.94e-05	0.000607	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—JUNB—systemic lupus erythematosus	4.93e-05	0.000607	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—FCGR3A—systemic lupus erythematosus	4.93e-05	0.000605	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CTLA4—systemic lupus erythematosus	4.92e-05	0.000605	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—RASGRP1—systemic lupus erythematosus	4.9e-05	0.000603	CbGpPWpGaD
Temsirolimus—Asthenia—Methotrexate—systemic lupus erythematosus	4.88e-05	0.000259	CcSEcCtD
Temsirolimus—MTOR—Immune System—RIPK1—systemic lupus erythematosus	4.86e-05	0.000598	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—CDKN1B—systemic lupus erythematosus	4.85e-05	0.000596	CbGpPWpGaD
Temsirolimus—CYP2D6—Biological oxidations—RXRA—systemic lupus erythematosus	4.83e-05	0.000594	CbGpPWpGaD
Temsirolimus—Nausea—Prednisone—systemic lupus erythematosus	4.83e-05	0.000256	CcSEcCtD
Temsirolimus—FKBP1A—Signaling Pathways—CSK—systemic lupus erythematosus	4.81e-05	0.000592	CbGpPWpGaD
Temsirolimus—Pruritus—Methotrexate—systemic lupus erythematosus	4.81e-05	0.000255	CcSEcCtD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—IL6—systemic lupus erythematosus	4.78e-05	0.000588	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	4.71e-05	0.00058	CbGpPWpGaD
Temsirolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—systemic lupus erythematosus	4.71e-05	0.000579	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—RASGRP1—systemic lupus erythematosus	4.71e-05	0.000579	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TLR9—systemic lupus erythematosus	4.7e-05	0.000578	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD79A—systemic lupus erythematosus	4.69e-05	0.000577	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—CDKN1A—systemic lupus erythematosus	4.68e-05	0.000575	CbGpPWpGaD
Temsirolimus—Diarrhoea—Methotrexate—systemic lupus erythematosus	4.65e-05	0.000247	CcSEcCtD
Temsirolimus—ABCB1—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	4.56e-05	0.00056	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PRL—systemic lupus erythematosus	4.55e-05	0.000559	CbGpPWpGaD
Temsirolimus—Dizziness—Methotrexate—systemic lupus erythematosus	4.49e-05	0.000238	CcSEcCtD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—CDKN1A—systemic lupus erythematosus	4.48e-05	0.00055	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by VEGF—IL6—systemic lupus erythematosus	4.45e-05	0.000547	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by Insulin receptor—IL6—systemic lupus erythematosus	4.42e-05	0.000543	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NCF2—systemic lupus erythematosus	4.4e-05	0.000541	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL2—systemic lupus erythematosus	4.4e-05	0.000541	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—TYK2—systemic lupus erythematosus	4.39e-05	0.000539	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—LYN—systemic lupus erythematosus	4.37e-05	0.000538	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HLA-DQA1—systemic lupus erythematosus	4.33e-05	0.000532	CbGpPWpGaD
Temsirolimus—Vomiting—Methotrexate—systemic lupus erythematosus	4.32e-05	0.000229	CcSEcCtD
Temsirolimus—ABCB1—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	4.32e-05	0.000531	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SH2B3—systemic lupus erythematosus	4.29e-05	0.000528	CbGpPWpGaD
Temsirolimus—Rash—Methotrexate—systemic lupus erythematosus	4.29e-05	0.000227	CcSEcCtD
Temsirolimus—Dermatitis—Methotrexate—systemic lupus erythematosus	4.28e-05	0.000227	CcSEcCtD
Temsirolimus—Headache—Methotrexate—systemic lupus erythematosus	4.26e-05	0.000226	CcSEcCtD
Temsirolimus—MTOR—Immune System—CSK—systemic lupus erythematosus	4.19e-05	0.000515	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—MBL2—systemic lupus erythematosus	4.15e-05	0.000511	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IRF5—systemic lupus erythematosus	4.12e-05	0.000507	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HLA-DQB1—systemic lupus erythematosus	4.05e-05	0.000498	CbGpPWpGaD
Temsirolimus—Nausea—Methotrexate—systemic lupus erythematosus	4.04e-05	0.000214	CcSEcCtD
Temsirolimus—MTOR—Cellular responses to stress—CDKN1B—systemic lupus erythematosus	3.98e-05	0.000489	CbGpPWpGaD
Temsirolimus—MTOR—Disease—HIST2H2AC—systemic lupus erythematosus	3.97e-05	0.000488	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IFIH1—systemic lupus erythematosus	3.94e-05	0.000484	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IRF8—systemic lupus erythematosus	3.94e-05	0.000484	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—ITGAM—systemic lupus erythematosus	3.94e-05	0.000484	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD247—systemic lupus erythematosus	3.94e-05	0.000484	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CSK—systemic lupus erythematosus	3.87e-05	0.000475	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	3.86e-05	0.000475	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—NCF2—systemic lupus erythematosus	3.83e-05	0.000471	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD40LG—systemic lupus erythematosus	3.83e-05	0.00047	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—LYN—systemic lupus erythematosus	3.8e-05	0.000468	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—JAK1—systemic lupus erythematosus	3.8e-05	0.000467	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD8A—systemic lupus erythematosus	3.78e-05	0.000465	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—IL6—systemic lupus erythematosus	3.78e-05	0.000464	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—FCGR2A—systemic lupus erythematosus	3.76e-05	0.000462	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—VEGFA—systemic lupus erythematosus	3.74e-05	0.00046	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—CDKN1B—systemic lupus erythematosus	3.73e-05	0.000459	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	3.72e-05	0.000458	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TNFAIP3—systemic lupus erythematosus	3.69e-05	0.000453	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—CDKN1A—systemic lupus erythematosus	3.67e-05	0.000451	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—BLK—systemic lupus erythematosus	3.64e-05	0.000448	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—JAK1—systemic lupus erythematosus	3.64e-05	0.000447	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CD247—systemic lupus erythematosus	3.64e-05	0.000447	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—IL6—systemic lupus erythematosus	3.61e-05	0.000444	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—IL6—systemic lupus erythematosus	3.56e-05	0.000437	CbGpPWpGaD
Temsirolimus—MTOR—Disease—NCF2—systemic lupus erythematosus	3.54e-05	0.000435	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—C3—systemic lupus erythematosus	3.52e-05	0.000433	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CXCL12—systemic lupus erythematosus	3.52e-05	0.000433	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—EP300—systemic lupus erythematosus	3.49e-05	0.000429	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—JUNB—systemic lupus erythematosus	3.46e-05	0.000425	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CCR5—systemic lupus erythematosus	3.45e-05	0.000424	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—CDKN1A—systemic lupus erythematosus	3.44e-05	0.000423	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	3.43e-05	0.000422	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—IL6—systemic lupus erythematosus	3.4e-05	0.000418	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—C3—systemic lupus erythematosus	3.38e-05	0.000416	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—IL6—systemic lupus erythematosus	3.38e-05	0.000416	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—IL6—systemic lupus erythematosus	3.36e-05	0.000414	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CRP—systemic lupus erythematosus	3.35e-05	0.000412	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—IL6—systemic lupus erythematosus	3.35e-05	0.000412	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—VEGFA—systemic lupus erythematosus	3.31e-05	0.000407	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	3.28e-05	0.000404	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PTPRC—systemic lupus erythematosus	3.26e-05	0.0004	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL1RN—systemic lupus erythematosus	3.24e-05	0.000399	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—TLR4—systemic lupus erythematosus	3.21e-05	0.000395	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	3.2e-05	0.000394	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PRL—systemic lupus erythematosus	3.18e-05	0.000391	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	3.16e-05	0.000388	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—systemic lupus erythematosus	3.15e-05	0.000387	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—IL6—systemic lupus erythematosus	3.15e-05	0.000387	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—IL6—systemic lupus erythematosus	3.15e-05	0.000387	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—IL6—systemic lupus erythematosus	3.12e-05	0.000384	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—IL6—systemic lupus erythematosus	3.09e-05	0.00038	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HLA-DRB1—systemic lupus erythematosus	3.08e-05	0.000379	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—IL6—systemic lupus erythematosus	3.08e-05	0.000379	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TLR9—systemic lupus erythematosus	3.04e-05	0.000373	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD40—systemic lupus erythematosus	3.03e-05	0.000372	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CTLA4—systemic lupus erythematosus	2.98e-05	0.000367	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HMGB1—systemic lupus erythematosus	2.98e-05	0.000367	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CD80—systemic lupus erythematosus	2.96e-05	0.000364	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—P2RY12—systemic lupus erythematosus	2.94e-05	0.000362	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IFNA1—systemic lupus erythematosus	2.93e-05	0.00036	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—NAT2—systemic lupus erythematosus	2.87e-05	0.000353	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—RASGRP1—systemic lupus erythematosus	2.86e-05	0.000351	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD79A—systemic lupus erythematosus	2.85e-05	0.00035	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD80—systemic lupus erythematosus	2.85e-05	0.00035	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CD80—systemic lupus erythematosus	2.83e-05	0.000348	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—systemic lupus erythematosus	2.79e-05	0.000343	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	2.78e-05	0.000342	CbGpPWpGaD
Temsirolimus—MTOR—Disease—JUNB—systemic lupus erythematosus	2.77e-05	0.000341	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PRL—systemic lupus erythematosus	2.77e-05	0.00034	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CSK—systemic lupus erythematosus	2.71e-05	0.000333	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-DQA1—systemic lupus erythematosus	2.63e-05	0.000323	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PRL—systemic lupus erythematosus	2.56e-05	0.000314	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—JAK1—systemic lupus erythematosus	2.55e-05	0.000313	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—TYK2—systemic lupus erythematosus	2.5e-05	0.000308	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NCF2—systemic lupus erythematosus	2.48e-05	0.000304	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—LYN—systemic lupus erythematosus	2.46e-05	0.000302	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-DQB1—systemic lupus erythematosus	2.46e-05	0.000302	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SH2B3—systemic lupus erythematosus	2.41e-05	0.000297	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCR5—systemic lupus erythematosus	2.41e-05	0.000297	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—TYK2—systemic lupus erythematosus	2.39e-05	0.000294	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.38e-05	0.000292	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—C3—systemic lupus erythematosus	2.36e-05	0.00029	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—NOS3—systemic lupus erythematosus	2.35e-05	0.000289	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	2.34e-05	0.000288	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL18—systemic lupus erythematosus	2.33e-05	0.000286	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD40LG—systemic lupus erythematosus	2.32e-05	0.000285	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD8A—systemic lupus erythematosus	2.29e-05	0.000282	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—IL6—systemic lupus erythematosus	2.29e-05	0.000281	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CD4—systemic lupus erythematosus	2.26e-05	0.000278	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	2.22e-05	0.000273	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—JAK1—systemic lupus erythematosus	2.21e-05	0.000272	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD4—systemic lupus erythematosus	2.17e-05	0.000267	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CD4—systemic lupus erythematosus	2.16e-05	0.000266	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PTGS2—systemic lupus erythematosus	2.15e-05	0.000264	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—IL6—systemic lupus erythematosus	2.15e-05	0.000264	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CDKN1B—systemic lupus erythematosus	2.13e-05	0.000262	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—NAT2—systemic lupus erythematosus	2.07e-05	0.000255	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—F2—systemic lupus erythematosus	2.07e-05	0.000254	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL2RA—systemic lupus erythematosus	2.07e-05	0.000254	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—C3—systemic lupus erythematosus	2.05e-05	0.000252	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	2.05e-05	0.000252	CbGpPWpGaD
Temsirolimus—MTOR—Disease—JAK1—systemic lupus erythematosus	2.04e-05	0.000251	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CDKN1B—systemic lupus erythematosus	2.04e-05	0.000251	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CDKN1B—systemic lupus erythematosus	2.03e-05	0.00025	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CD80—systemic lupus erythematosus	1.98e-05	0.000244	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.98e-05	0.000243	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CDKN1A—systemic lupus erythematosus	1.96e-05	0.000241	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CRP—systemic lupus erythematosus	1.95e-05	0.00024	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.95e-05	0.000239	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—JUNB—systemic lupus erythematosus	1.94e-05	0.000239	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CCR5—systemic lupus erythematosus	1.94e-05	0.000238	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CDKN1A—systemic lupus erythematosus	1.89e-05	0.000232	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CDKN1A—systemic lupus erythematosus	1.88e-05	0.000231	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.87e-05	0.00023	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TLR4—systemic lupus erythematosus	1.87e-05	0.00023	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-DRB1—systemic lupus erythematosus	1.87e-05	0.00023	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—EP300—systemic lupus erythematosus	1.87e-05	0.00023	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.85e-05	0.000227	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCL2—systemic lupus erythematosus	1.84e-05	0.000227	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.84e-05	0.000227	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PRL—systemic lupus erythematosus	1.79e-05	0.00022	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—EP300—systemic lupus erythematosus	1.79e-05	0.00022	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD80—systemic lupus erythematosus	1.73e-05	0.000212	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.69e-05	0.000208	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TYK2—systemic lupus erythematosus	1.68e-05	0.000206	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NOS3—systemic lupus erythematosus	1.64e-05	0.000202	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—RXRA—systemic lupus erythematosus	1.61e-05	0.000198	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CD80—systemic lupus erythematosus	1.59e-05	0.000196	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.58e-05	0.000194	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	1.56e-05	0.000192	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—TGFB1—systemic lupus erythematosus	1.55e-05	0.000191	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	1.47e-05	0.000181	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TYK2—systemic lupus erythematosus	1.46e-05	0.000179	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—JAK1—systemic lupus erythematosus	1.43e-05	0.000176	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.42e-05	0.000175	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL2—systemic lupus erythematosus	1.39e-05	0.000171	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IFNG—systemic lupus erythematosus	1.36e-05	0.000168	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCR5—systemic lupus erythematosus	1.36e-05	0.000167	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TYK2—systemic lupus erythematosus	1.35e-05	0.000165	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.34e-05	0.000164	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—C3—systemic lupus erythematosus	1.33e-05	0.000163	CbGpPWpGaD
Temsirolimus—MTOR—Disease—NOS3—systemic lupus erythematosus	1.32e-05	0.000162	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MMP9—systemic lupus erythematosus	1.32e-05	0.000162	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD4—systemic lupus erythematosus	1.32e-05	0.000162	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.31e-05	0.000162	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—EP300—systemic lupus erythematosus	1.25e-05	0.000154	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CDKN1B—systemic lupus erythematosus	1.24e-05	0.000152	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IL6—systemic lupus erythematosus	1.22e-05	0.00015	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CD4—systemic lupus erythematosus	1.22e-05	0.00015	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL2—systemic lupus erythematosus	1.21e-05	0.000149	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PTGS2—systemic lupus erythematosus	1.21e-05	0.000148	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.18e-05	0.000146	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—IL6—systemic lupus erythematosus	1.17e-05	0.000144	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—F2—systemic lupus erythematosus	1.16e-05	0.000143	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—RXRA—systemic lupus erythematosus	1.16e-05	0.000143	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CDKN1B—systemic lupus erythematosus	1.14e-05	0.000141	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CDKN1A—systemic lupus erythematosus	1.14e-05	0.000141	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CD80—systemic lupus erythematosus	1.12e-05	0.000137	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—EP300—systemic lupus erythematosus	1.09e-05	0.000134	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.09e-05	0.000134	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.06e-05	0.000131	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CDKN1A—systemic lupus erythematosus	1.06e-05	0.00013	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCL2—systemic lupus erythematosus	1.04e-05	0.000128	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PPARG—systemic lupus erythematosus	1.01e-05	0.000125	CbGpPWpGaD
Temsirolimus—MTOR—Disease—EP300—systemic lupus erythematosus	1e-05	0.000124	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	9.64e-06	0.000118	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TYK2—systemic lupus erythematosus	9.42e-06	0.000116	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NOS3—systemic lupus erythematosus	9.25e-06	0.000114	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ALB—systemic lupus erythematosus	9.13e-06	0.000112	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	8.77e-06	0.000108	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TGFB1—systemic lupus erythematosus	8.73e-06	0.000107	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—NOS3—systemic lupus erythematosus	8.73e-06	0.000107	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	8.26e-06	0.000102	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL6—systemic lupus erythematosus	8.19e-06	0.000101	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CDKN1B—systemic lupus erythematosus	8.01e-06	9.85e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PTGS2—systemic lupus erythematosus	7.98e-06	9.82e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL2—systemic lupus erythematosus	7.84e-06	9.64e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MMP9—systemic lupus erythematosus	7.42e-06	9.12e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CDKN1A—systemic lupus erythematosus	7.39e-06	9.09e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PPARG—systemic lupus erythematosus	7.34e-06	9.02e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL6—systemic lupus erythematosus	7.13e-06	8.76e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—EP300—systemic lupus erythematosus	7.03e-06	8.65e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—VEGFA—systemic lupus erythematosus	6.66e-06	8.19e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—EP300—systemic lupus erythematosus	6.64e-06	8.16e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ALB—systemic lupus erythematosus	6.6e-06	8.11e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IL6—systemic lupus erythematosus	6.58e-06	8.09e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—NOS3—systemic lupus erythematosus	6.31e-06	7.76e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TGFB1—systemic lupus erythematosus	6.12e-06	7.52e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PTGS2—systemic lupus erythematosus	5.77e-06	7.09e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	5.54e-06	6.81e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	5.4e-06	6.64e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	5.22e-06	6.41e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ALB—systemic lupus erythematosus	4.98e-06	6.12e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—EP300—systemic lupus erythematosus	4.8e-06	5.9e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	4.76e-06	5.85e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	4.69e-06	5.77e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL6—systemic lupus erythematosus	4.61e-06	5.67e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	4.49e-06	5.52e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	4.35e-06	5.35e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	4.1e-06	5.05e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—EP300—systemic lupus erythematosus	3.62e-06	4.45e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	3.41e-06	4.2e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	3.41e-06	4.19e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	3.07e-06	3.77e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	2.93e-06	3.61e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	2.68e-06	3.3e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	2.23e-06	2.74e-05	CbGpPWpGaD
